4th Quarter - Report
STANTON PARK GROUP for VERTEX PHARMACEUTICALS INCORPORATED
Firm
Income
$30,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Awareness of the Hepatitis C virus, the rising costs associated with the disease and the need for greater emphasis on testing for and treatment of the disease. Awareness of Cystic Fibrosis and the treatments available. Pandemic influenza.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES DERDERIAN | CoS, House Commerce; LA, LD, Rep. Bliley |
| VALERIE HENRY | Policy Advisor, Rep. Walden |
| ERIN STRAWN | SA, EA, LA, LD Rep. C. Weldon |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.